New hope for patients Who've run out of options: experimental cancer drug enters human testing
Disease control
Recruiting now
This is the first study in people testing a new drug called UBX-303061 for patients with advanced B-cell cancers that have returned or stopped responding to standard treatments. The main goals are to find a safe dose and see how the body processes the drug. Researchers will also …
Phase: PHASE1 • Sponsor: Ubix Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC